Segmentation by type classifies portable imaging devices into ultrasound, X‑ray, magnetic resonance (MRI), computed tomography (CT), and nuclear‑medicine (PET/SPECT) families. Portable ultrasound dominates the market, contributing over 60 % of sales, owing to its versatility across obstetrics, cardiology, and musculoskeletal examinations, as well as its relatively low power consumption and cost. Handheld X‑ray systems, accounting for roughly 20 % of revenue, address orthopedic trauma and bedside chest imaging, where rapid image acquisition can influence clinical decision‑making. Portable MRI and CT units remain niche, together representing about 12 % of the market; their adoption is limited by size, power requirements, and higher acquisition costs, yet they are expanding in specialized tertiary centers seeking on‑site advanced imaging. Nuclear‑medicine portable scanners, comprising the residual 8 %, serve targeted applications such as intra‑operative sentinel‑node detection and mobile cardiac stress testing. Each type’s contribution reflects a balance between clinical utility, technological maturity, and cost‑benefit considerations, forming the core of the market taxonomy for portable diagnostic imaging.